Prawo i regulacje · 16/08/2016

Bellwyck Clinical Services Seeks FDA Registration for Controlled Substances

The FDA is accepting written comments and objections on Bellwyck Clinical Services' application for registration as a bulk manufacturer of controlled substances until September 15, 2016, and also invites requests for a hearing on the matter by the same deadline.